>
pdufa.bio

IMU-838 tablets

Updated ยทnext FDA decision on the calendar

IMU-838 tablets is a Immunic, Inc. program. Its next catalyst is a Readout in Nov 2026. Every date links its source.

IMUX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Immunic, Inc. (IMUX). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Nov 2026IMUX

Questions

When is IMU-838 tablets's next FDA decision or readout?

The next tracked catalyst for IMU-838 tablets is a Readout in Nov 2026.

What happened at IMU-838 tablets's most recent FDA decision?

No FDA decision for IMU-838 tablets is in our archive yet.

Who makes IMU-838 tablets?

Immunic, Inc. (IMUX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.